ACCESSION: MSBNK-SMB_Measured-HSA031P0545001
RECORD_TITLE: Uncharacterized; LC-ESI-QTOF; MS2; NEGATIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.24, Processed 2025.02.24, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Yu et al. Front Cell Infect Microbiol. 2022,11,763507
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS3233
COMMENT: DATASET_TITLE The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis
COMMENT: DATASET_AUTHORS Die Yu, Juping Du, Xia Pu, Liyuan Zheng, Shuaishuai Chen, Na Wang, Jun Li, Shiyong Chen, Shaobiao Pan, Bo Shen
COMMENT: MS1_M/Z_AVERAGED_THRES 10.000
COMMENT: MS2_M/Z_AVERAGED_THRES 15.000
COMMENT: DATASET_FILE_NUM 59
COMMENT: NUM_AVERAGED_SPEC 12
COMMENT: RAW_SPEC {'RA1-neg_2587': {'bp': 2521.0, 'sum': 5823.0}, 'HC5-neg_2583': {'bp': 2074.0, 'sum': 3292.0}, 'HC12-neg_2862': {'bp': 1510.0, 'sum': 2628.0}, 'RA10-neg_2703': {'bp': 1170.0, 'sum': 2189.0}, 'RA2-neg_2729': {'bp': 1167.0, 'sum': 2688.0}, 'HC19-neg_2580': {'bp': 950.0, 'sum': 1919.0}, 'HC10-neg_2744': {'bp': 939.0, 'sum': 2057.0}, 'RA5-neg_2649': {'bp': 897.0, 'sum': 1355.0}, 'RA24-neg_2481': {'bp': 825.0, 'sum': 1839.0}, 'HC25-neg_2763': {'bp': 731.0, 'sum': 1343.0}, 'HC9-neg_2569': {'bp': 547.0, 'sum': 1106.0}, 'HC13-neg_2961': {'bp': 493.0, 'sum': 952.0}}
COMMENT: RETENTION_TIME_STDEV 0.005
COMMENT: PRECURSOR_M/Z_RAW 545.281753
COMMENT: PRECURSOR_M/Z_STDEV 0.001662
COMMENT: PRECURSOR_IN_MS1 mz 545.280456; int 261.361; delta(ppm) 2.650413
COMMENT: PROPOSED_CHARGE_STATE -1; mz 546.283343; int 94.796; cor 0.937
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+Na-2H; M-H2O-H; mz 505.278777; int 20.457; cor 0.717
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 9.308; C33H44N2OP2; [M-H]1; delta(ppm) -9.308280
COMMENT: PROPOSED_MF SevenGoldenRules 7.223; C22H47N2O11P; [M-H]1; delta(ppm) -7.223299
COMMENT: PROPOSED_MF SevenGoldenRules 4.201; C24H42N4O10; [M-H]1; delta(ppm) -4.201082
COMMENT: PROPOSED_MF SevenGoldenRules 3.837; C34H43O4P; [M-H]1; delta(ppm) -3.836805
COMMENT: PROPOSED_MF SevenGoldenRules 1.944; C28H44N4O3P2; [M-H]1; delta(ppm) -1.944030
COMMENT: PROPOSED_MF SevenGoldenRules 1.752; C23H46O14; [M-H]1; delta(ppm) -1.751824
COMMENT: PROPOSED_MF SevenGoldenRules 0.503; C27H48O7P2; [M-H]1; delta(ppm) 0.503398
COMMENT: PROPOSED_MF SevenGoldenRules 3.527; C29H43N2O6P; [M-H]1; delta(ppm) 3.527445
COMMENT: PROPOSED_MF SevenGoldenRules 6.551; C31H38N4O5; [M-H]1; delta(ppm) 6.551492
COMMENT: PROPOSED_MF SevenGoldenRules 7.868; C22H48N2O9P2; [M-H]1; delta(ppm) 7.867648
COMMENT: PROPOSED_MF SevenGoldenRules 8.999; C30H42O9; [M-H]1; delta(ppm) 8.998920
COMMENT: PROPOSED_MF SevenGoldenRules 8.636; C19H50N4O8P2; [M+Na-2H]1; delta(ppm) -8.636180
COMMENT: PROPOSED_MF SevenGoldenRules 7.456; C27H44N2O8; [M+Na-2H]1; delta(ppm) -7.455572
COMMENT: PROPOSED_MF SevenGoldenRules 5.106; C31H46N2OP2; [M+Na-2H]1; delta(ppm) -5.105798
COMMENT: PROPOSED_MF SevenGoldenRules 2.933; C20H49N2O11P; [M+Na-2H]1; delta(ppm) -2.933402
COMMENT: PROPOSED_MF SevenGoldenRules 0.216; C22H44N4O10; [M+Na-2H]1; delta(ppm) 0.215523
COMMENT: PROPOSED_MF SevenGoldenRules 0.595; C32H45O4P; [M+Na-2H]1; delta(ppm) 0.595073
COMMENT: PROPOSED_MF SevenGoldenRules 2.567; C26H46N4O3P2; [M+Na-2H]1; delta(ppm) 2.567204
COMMENT: PROPOSED_MF SevenGoldenRules 2.767; C21H48O14; [M+Na-2H]1; delta(ppm) 2.767469
COMMENT: PROPOSED_MF SevenGoldenRules 5.117; C25H50O7P2; [M+Na-2H]1; delta(ppm) 5.117242
COMMENT: PROPOSED_MF SevenGoldenRules 8.268; C27H45N2O6P; [M+Na-2H]1; delta(ppm) 8.268075
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 1.000; VODAHSRZQBCHLA-KCMDGGSUSA-N; C30H42O9; NCGC00380242-01C30H42O9Card-20(22)-enolide, 1,3-bis(acetyloxy)-14,15-epoxy-7,21-dihydroxy-4,4,8-trimethyl-, (1alpha,3alpha,7alpha,9xi,13alpha,15beta,17alpha)-
COMMENT: CONFIDENCE Level 5: Exact mass of interest 545.280523; Observed in MS1; Charge state -1;
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Feces
AC$INSTRUMENT: UPLC system, AB SCIEX - TripleTOF 5600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY -30 V
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE -4.5 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 10.00; MS2(ppm) 15.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC T3 column (1.8 Âµm, 100 mm x 2.1 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT 0.0-0.5 min, 5% B; 0.5-7.0 min, 100% B; 7.0-8.0 min, 100% B; 8.0-8.1 min, 5% B; 8.1-10.0 min, 5% B. 
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 3.309
MS$FOCUSED_ION: PRECURSOR_M/Z 545.280523
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0002-0000190000-6badc8a82f2f32422938
PK$ANNOTATION: m/z int annotation m/z_nocal m/z_std(ppm) int_std cor n
  482.2394183 131.8927 ? 482.235509 15.9298 50.66 0.7093 11
  545.2269030 110.9253 ? 545.229644 13.6163 91.11 0.4706 9
  545.2817753 999.0000 ? 545.284517 6.2995 0.00 1.0000 12
PK$NUM_PEAK: 3
PK$PEAK: m/z int. rel.int.
  482.239418 131.89 131
  545.226903 110.93 110
  545.281775 999.00 999
//
